Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sana Biotechnology, Inc. - Common Stock
(NQ:
SANA
)
4.300
+2.650 (+160.61%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sana Biotechnology, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
February 29, 2024
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference
February 28, 2024
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP
February 13, 2024
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Why Sana Biotechnology Shares Are Rising Today
January 05, 2024
Sana Biotechnology, Inc. (NASDAQ: SANA) announced the U.S.
Via
Benzinga
Sana Biotechnology Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 12, 2024
From
Sana Biotechnology, Inc
Via
GlobeNewswire
PayPal Reports Q4 Results, Joins Rapid7, GoPro And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
February 08, 2024
U.S. stock futures were mixed this morning, with the Dow futures trading lower by around 10 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Sana Biotechnology Announces Pricing of Upsized Public Offering
February 08, 2024
From
Sana Biotechnology, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 07, 2024
Via
Benzinga
Sana Biotechnology Announces Proposed Public Offering of Common Stock
February 07, 2024
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
January 12, 2024
A look at five stocks seeing increased attention from investors.
Via
Benzinga
Aspen Aerogels Issues Business Update, Joins Plug Power, SunPower And Other Big Stocks Moving Lower On Thursday
January 11, 2024
U.S. stocks traded lower, with the Dow Jones index falling over 150 points on Thursday. Shares of Aspen Aerogels, Inc. (NYSE: ASPN) fell sharply during Thursday’s session after the company issued a...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 10, 2024
Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 10, 2024
Via
Benzinga
Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC262, a Hypoimmune-modified, CD22-directed Allogeneic CAR T Therapy, for Patients with Relapsed or Refractory B-cell Malignancies
January 05, 2024
Expect to disclose initial SC262 clinical data in 2024
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Highlights Preclinical Data Supporting Tumor Control and Immune Evasion Capabilities of Hypoimmune-Modified Allogeneic CAR T Cells in Presentations at the American Society of Hematology Annual Meeting
December 11, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 04, 2023
Via
Benzinga
Sana Biotechnology Publishes Early Clinical Data Showing that SC291, a CD19-directed Allogeneic CAR T Therapy, Evades Immune Detection in Presence of Intact Immune System
December 01, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 04, 2023
Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20...
Via
Benzinga
Sana Biotechnology to Present at November and December 2023 Investor Conferences
November 21, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Uppsala University Hospital and Sana Biotechnology Announce Authorization of the First-in-Human Clinical Trial Application for a Primary Islet Cell Treatment for Patients with Type 1 Diabetes
November 17, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-directed Allogeneic CAR T Therapy, for Patients with Lupus Nephritis, Extrarenal Lupus, and ANCA-associated Vasculitis
November 09, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Reports Third Quarter 2023 Financial Results and Business Updates
November 08, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces Five Presentations at the 65th American Society of Hematology Annual Meeting
November 02, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Sana Biotechnology Announces Increased Focus on Hypoimmune-Related Pipeline with the Potential to Deliver Clinical Proof of Concept Data from Four Programs in 2023 and 2024 with a 2024 Operating Burn under $200M
October 10, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
September 25, 2023
Via
Benzinga
Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
September 13, 2023
Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 13, 2023
Via
Benzinga
Sana Biotechnology to Present at September 2023 Investor Conferences
August 30, 2023
From
Sana Biotechnology, Inc
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
September 05, 2023
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.